22.05 : 2012 .
01.01.2012 997,316 . 0,7% 5,2% . , 12 2012. 28734,3 . (927,81 .), 7% (26822,3 .).ԙ, 2012. 2%, 33,211 . . ( ) 2011. (+16%), (+10%), 3,587 . (115,697 . .) (.1). 0,9%. 4,44 . ( 3,97 .). 12 2012. 147,75 .
2012. SANOFI-AVENTIS (+19%) BAYER (+13%) (.1). SANDOZ (+14%) MERCK SHARP DOHME (+22%), . -10 . SERVIER (+24%), TEVA (+38%) ABBOTT (+26%). , 8 9 , NOVARTIS (+20%) NYCOMED/TAKEDA (+18%). , PHARMSTANDART (-8%). , , 38,3% 38,6%.
(. 2). 6 8 ALFLUTOP (+45%), PEGINTRON (+37%) KAGOCEL, 3,2 . , CONCOR (+24%). ESSENTIALE N (+42%) ACTOVEGIN (+28%) , . TROPICAMID (-13%), VIAGRA (-7%) ARBIDOL (-31%) . - , , . , 9 , KETONAL (+6%), .
-10 (.3). , PHOSPHOLIPIDS (+40%), KETOPROFEN (+15%), XYLOMETAZOLINE (+33%) PANCREATIN (+18%). , 7 9 , PARACETAMOL + ASCORBIC ACID + PHENIRAMINE (+8%) BISOPROLOL (+25%). BLOOD (+29%). : TROPICAMIDE (-12%) UMIFENOVIR (-31%), 5 8 . SILDENAFIL (+1%) . , , , 0,5 .. 10,2%.
-10 N02 (-6%) M01 (+22%) (.4). , - R05 (-1%).